Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Zhong-qiu Lin"'
Publikováno v:
Journal of Ovarian Research, Vol 14, Iss 1, Pp 1-8 (2021)
Abstract Background Hyperthermic intraperitoneal chemotherapy (HIPEC) is an important treatment for ovarian cancer. A certain portion of cisplatin exits the body via the perfusate at the end of HIPEC, so full-dose utilization cannot be achieved. Here
Externí odkaz:
https://doaj.org/article/ab3a7c85606d464ea0fdb5e67c7ef852
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Background: To identify the maximum tolerated dose (MTD) of hyperthermic intraperitoneal cisplatin at 43°C among gynecological cancer patients.Methods: In this Phase I dose-finding trial, Bayesian optimal interval (BOIN) design was used. We sought t
Externí odkaz:
https://doaj.org/article/071625b67e4d4101b6c990602b547312
Autor:
Yu-tao Guan, Yong Xie, Hui Zhou, Hai-yan Shi, Yu-yuan Zhu, Xiao-lu Zhang, Yi Luan, Xi-ming Shen, Yang-ping Chen, Li-jiang Xu, Zhong-qiu Lin, Gang Wang
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Cervical carcinoma is a major gynecological cancer and causes cancer-related deaths in worldwide, the latent pathogenesis and progress of cervical cancer is still under research. ClC-3 may be an important promoter for aggressive m
Externí odkaz:
https://doaj.org/article/71f76d47ba044320931824c8388ac7ef
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background To investigate whether poor glycemic control status has a negative impact on survival outcomes and tumor response to chemotherapy in patients receiving neoadjuvant chemotherapy (NACT) for locally advanced cervical cancer (LACC). M
Externí odkaz:
https://doaj.org/article/9ea240dc4f3b428aa8e3ef561797261a
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0166612 (2016)
The impact of hyperglycemia on survival of patients undergoing neoadjuvant chemotherapy (NACT) for bulky early stage cervical cancer (BESCC) has not been explored.Records of patients who received NACT and radical hysterectomy in our institution betwe
Externí odkaz:
https://doaj.org/article/95fee731b3704227a4f46ee6434a0a60
Publikováno v:
Drugs & Aging. 40:539-549
Publikováno v:
Journal of Gynecologic Oncology; Jan2024, Vol. 35 Issue 1, p1-13, 13p
Autor:
Miao-Fang Wu, Li-Juan Wang, Yan-Fang Ye, Chang-Hao Liu, Huai-Wu Lu, Ting-Ting Yao, Bing-Zhong Zhang, Qing Chen, Ji-Bin Li, Yong-Pai Peng, Hui Zhou, Zhong-Qiu Lin, Jing Li
Publikováno v:
BMJ Open
BackgroundNeoadjuvant chemotherapy (NACT) is an important treatment option for patients with ovarian cancer. Although intravenous NACT can improve optimal resection rates and decrease surgical morbidity and mortality, these advantages do not translat
Autor:
Yutao Guan, Yang-ping Chen, Gang Wang, Yong Xie, Hai-yan Shi, Li-jiang Xu, Xiao-lu Zhang, Yi Luan, Xi-ming Shen, Hui Zhou, Zhong-qiu Lin, Yu-yuan Zhu
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-11 (2019)
Cancer Cell International
Cancer Cell International
Background Cervical carcinoma is a major gynecological cancer and causes cancer-related deaths in worldwide, the latent pathogenesis and progress of cervical cancer is still under research. ClC-3 may be an important promoter for aggressive metastasis
Autor:
Mahsa Hoshmand-Kochi, Timothy Q. Duong, Beiyi Shen, Zhong Qiu Lin, Alexander Wong, Linda Wang, Almas F. Abbasi, A. G. Chung
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
A critical step in effective care and treatment planning for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause for the coronavirus disease 2019 (COVID-19) pandemic, is the assessment of the severity of disease progression. Chest